Tetra Radar · FDA Approvals · Decision date

Valtoco: FDA decision date

Aquestive Therapeutics Inc (AQST) · 29 March 2027

The Company has also submitted a Type 9 NDA seeking to add patients six to eleven years of age to the label, with a PDUFA goal date of March 29, 2027.

Source: 10-Q of 3 November 2026

The decision is pending.

Aquestive Therapeutics Inc on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.